Does baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein induce Protective Immunity against RSV Infection without Vaccine-Enhanced Disease?
Our data demonstrate that intranasal administration of baculovirus-based Bac-RSV/G vaccine is efficient for the induction of protection against RSV and represents a promising prophylactic vaccination regimen.
State-level HS graduation rates, CR programs expressed as programs per population, and median income were strongly associated with geographic variations in CR participation rates.